Australian researchers have identified a previously unrecognized group of nerves near the bladder lining that play a critical role in detecting urinary tract infections (UTIs), a common condition affecting one in three women before the age of 24. The discovery offers a promising new avenue for developing treatments targeting bladder pain.
The study, led by Cindy Tay, found that these mucosal nerves, which have long puzzled scientists because they remain dormant during normal bladder filling and emptying, instead function as an early warning system that activates promptly when an infection begins. Unlike the nerves responsible for signaling bladder fullness, these nerves specifically detect infection and inflammation.
Luke Grundy, head of the NeuroUrology Research Group at Flinders University, described the findings as a potential breakthrough for pain management research. “We think we’ve discovered what is essentially a master regulator of pain in the bladder,” he said, emphasizing the therapeutic potential. Because these nerves do not contribute to normal bladder function, blocking their activity might relieve pain without impairing urination, a sought-after quality in pain treatment development.
Functionally, these nerves contribute to more than just sensing infection; they also coordinate the body's defensive responses by triggering pain and increased urinary frequency. These symptoms may encourage bacteria clearance from the bladder, highlighting the nerves’ dual role in both detection and defence.
UTIs are particularly prevalent in elderly populations and individuals with spinal cord injuries, with some experiencing multiple infections annually. Common symptoms include frequent urination, urgency, painful urination, and pelvic discomfort.
Researchers caution that future therapies must strike a balance between alleviating pain and urgency caused by UTIs and maintaining the protective function of these mucosal nerves. Developing drugs that target these nerves without compromising the body's ability to respond to infection remains the next significant challenge.
